1599P Symptomatic skeletal events, health-related quality of life and pain in a phase III study of [177Lu]Lu-PSMA-617 in taxane-naive patients with PSMA-positive metastatic castration-resistant prostate cancer: Third interim analysis of PSMAfore.

Authors :: Fizazi, K.
Morris, M.J.
Shore, N.D.
Chi, K.N.
Crosby, M.
de Bono, J.S.
Herrmann, K.
Roubaud, G.
Nagarajah, J.
Fleming, M.T.
Lewis, B.
Nordquist, L.T.
Castellano Gauna, D.E.
Carnahan, N.
Ghebremariam, S.
Hertelendi, M.
Sartor, O.
Source :: Annals of Oncology. 2024 Supplement 2, Vol. 35, pS964-S965. 2p.
Publication Year :: 2024

Full Text Access

Tools